Leadership Overview
Zoetis has 4 executives leading key functions including technology transformation, regional information systems, financial operations, and executive office management.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines, vaccines, and diagnostic products to improve the lives of livestock and companion animals globally.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines, vaccines, and diagnostic products to improve the lives of livestock and companion animals globally.
Leadership Roles at Zoetis
Lee Penn - Senior Director, Chief of Staff, Office of the Chief Executive Officer
Lee Penn, the Senior Director, Chief of Staff, Office of the Chief Executive Officer at Zoetis, coordinates the strategic priorities and daily operations of the executive leadership team. Overseeing the flow of information between the Board and senior management, the Senior Director, Chief of Staff, Office of the Chief Executive Officer ensures that corporate initiatives regarding animal health medicines and vaccines remain on schedule. This leadership role involves facilitating cross-functional collaboration to execute the company's long-term vision for global market expansion. By managing high-level projects and internal communications, Lee Penn directly impacts the alignment of organizational goals with the needs of veterinarians and livestock producers. Penn maintains a focus on operational excellence and strategic agility. Through the orchestration of executive meetings and policy implementation, the Senior Director, Chief of Staff, Office of the Chief Executive Officer supports the overall mission of the company, ensuring that leadership decisions translate into effective commercial outcomes across all international markets.
Renato Vilas Boas - Regional Chief Financial Officer, Latin America (Canada)
Renato Vilas Boas, the Regional Chief Financial Officer, Latin America (Canada) at Zoetis, governs the financial health and fiscal planning for operations across the Americas. Overseeing capital allocation for regional veterinary product distribution, the Regional Chief Financial Officer, Latin America (Canada) ensures that resource distribution aligns with the specific needs of livestock and companion animal markets. This leadership role involves managing complex currency fluctuations and regional economic variables to maintain stable profit margins. By implementing robust financial reporting frameworks, Renato Vilas Boas directly impacts the strategic investment decisions regarding new pharmaceutical product launches. Boas collaborates with regional business units to optimize cost structures and drive sustainable revenue growth. Through the rigorous oversight of regional financial performance, the Regional Chief Financial Officer, Latin America (Canada) secures the necessary funding for ongoing research and development initiatives, ultimately bolstering the company's competitive advantage in the diverse and evolving animal health landscape.
Mark Chomow - Chief Technology Officer & Head of Transformation & Portfolio Management
Mark Chomow, the Chief Technology Officer & Head of Transformation & Portfolio Management at Zoetis, directs the integration of digital infrastructure across global manufacturing and research facilities. Overseeing the modernization of pharmaceutical development pipelines, the Chief Technology Officer & Head of Transformation & Portfolio Management ensures that data-driven insights accelerate the discovery of vaccines and diagnostic products. This leadership role involves aligning complex portfolio management strategies with long-term corporate growth objectives. By optimizing internal technical workflows, Mark Chomow directly impacts the efficiency of animal health product commercialization. Chomow maintains rigorous standards for digital security and operational agility, supporting the company's mission to provide high-quality veterinary solutions. Through the implementation of scalable technology frameworks, the Chief Technology Officer & Head of Transformation & Portfolio Management drives continuous improvement in the development of medicines for livestock and companion animals, ultimately strengthening the market position of the organization.
Michael Tao - Chief Information Officer, Greater (China, APAC)
Michael Tao, the Chief Information Officer, Greater (China, APAC) at Zoetis, manages the information technology landscape across the Asia-Pacific region. Overseeing the deployment of regional diagnostic data systems, the Chief Information Officer, Greater (China, APAC) ensures seamless connectivity between veterinary distributors and local manufacturing hubs. This leadership role involves tailoring digital health platforms to meet the specific regulatory and market requirements of the Chinese and broader APAC animal health sectors. By streamlining supply chain visibility through advanced analytics, Michael Tao directly impacts the availability of pharmaceutical products for livestock producers and veterinarians. Tao coordinates with global leadership to harmonize regional IT strategies with international standards. Through the enhancement of local digital infrastructure, the Chief Information Officer, Greater (China, APAC) supports the expansion of the company's footprint in high-growth markets, ensuring that veterinary professionals receive timely access to critical diagnostic tools and therapeutic solutions.
Explore Leadership Teams in Manufacturing
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership
MD
YY
ML
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB

Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.
Company Leadership TI
RN
FA